Research has shown that 'best if used by' – not, say not 'best by' or 'sell by' – helps shoppers better understand they don't need to throw foods out after the printed date passes if they're stored correctly.
The Food and Drug Administration announced Thursday that it strongly supports the food industry’s efforts to standardize date labeling. Research has shown that"best if used by" – not, say not “best by” or “sell by” – helps shoppers better understand they don’t need to throw foods out after the printed date passes if they’re stored correctly.
In its letter to the food industry, the FDA cites the U.S. Department of Agriculture’s Economic Research Service, estimating that every year Americans chuck 133 billion pounds of food, worth $161 billion. About 20% of consumer food waste stems from confusion over date labeling. He added that standardizing date labels isn't enough to effect change alone, so consumer education by industry, government, and non-government organizations must be part of the effort, too.
But the terminology simplification comes in part from an effort begun in 2017 by two trade groups, the Grocery Manufacturers Association and Food Marketing Institute.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
“Best if used by.FDA supports manufacturers’ use of the phrase “Best If Used By” to cut down on date confusion
Lire la suite »
Is Tahini safe? More brands recalled over Salmonella outbreak linkThe FDA are advising people not to eat Karawan, El-Karawan, or SoCo labeled tahini products.
Lire la suite »
FDA approves Novartis' $2.1 million gene therapy — making it the world's most expensive drugThe therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every 11,000 live births.
Lire la suite »
Gene therapy gets FDA approval -- and a $2 million price tagThe FDA approved a treatment for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2. The price tag? $2.125 million for a one-time treatment.
Lire la suite »
The FDA approves a gene therapy that is the most expensive drug in the worldThe gene therapy Zolgensma, priced at $2.1 million, treats infants with spinal muscular atrophy.
Lire la suite »
Novartis' breast cancer treatment wins FDA approvalThe U.S. Food and Drug Administration (FDA) said on Friday that it had approved ...
Lire la suite »
$2.1 million drug to treat rare genetic disease approved by FDAThe drug, Zolgensma, is being called a 'miracle drug' and will be used to treat children with spinal muscular atrophy, or SMA.
Lire la suite »
A new drug costs $2.1 million for children with a muscle-wasting diseaseA new drug for treating a rare disease in infants and toddlers is priced at $425,000 per year over five years and is poised to become the nation's most expensive drug.
Lire la suite »
At $2 Million, New Novartis Drug Is Priciest EverNovartis said it plans to price its recently approved gene therapy at $2.125 million, making it the world’s most expensive medicine.
Lire la suite »
Buyer beware: So-called sexual enhancement pills sold online can be dangerous for menThe FDA is warning consumers to stay away from dietary supplements claiming to promote sexual enhancement, weight loss or bodybuilding because they may contain hidden ingredients.
Lire la suite »
The FDA just approved a new treatment for a devastating disease. The price tag is more than $2 million.The treatment, called Zolgensma, should work longer than the typical drug, but also has a much higher price tag.
Lire la suite »